Boothbay Fund Management, LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$8.02 - $11.0 $84,570 - $115,995
-10,545 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$7.59 - $10.48 $160,065 - $221,012
-21,089 Reduced 66.67%
10,545 $62,000
Q1 2021

May 17, 2021
SELL
$6.86 - $9.24 $65,334 - $88,001
-9,524 Reduced 23.14%
31,634 $225,000
Q4 2020

Feb 12, 2021
BUY
$5.0 - $7.5 $205,790 - $308,685
41,158 New
41,158 $321,000

About Cyclacel Pharmaceuticals, Inc.

CYCC Quotes by TradingView
  • Ticker CYCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,539,200
  • Market Cap $4.51M
  • Description
  • Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...
More about CYCC
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email